Jacobs Levy Equity Management, Inc Astria Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $25.8 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$4.42 - $8.06 $39,360 - $71,774
-8,905 Reduced 5.51%
152,732 $1.17 Million
Q3 2023

Nov 16, 2023
BUY
$6.89 - $9.86 $219,487 - $314,100
31,856 Added 24.55%
161,637 $1.21 Million
Q2 2023

Aug 14, 2023
BUY
$8.33 - $13.72 $992,169 - $1.63 Million
119,108 Added 1115.97%
129,781 $1.08 Million
Q1 2023

May 15, 2023
BUY
$11.2 - $15.79 $119,537 - $168,526
10,673 New
10,673 $141,000

About Astria Therapeutics, Inc.

ATXS Quotes by TradingView
  • Ticker ATXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,178,000
  • Market Cap $97.3M
  • Description
  • Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...
More about ATXS
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email